Related Experiment Video
Updated: Dec 13, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization
Issam Kably1,2, Alexander Bode1
1Jackson Memorial Hospital, Department of Vascular and Interventional Radiology (R-109), PO Box 016960, Miami, FL, USA.
Giant prostatic hyperplasia (GPH) can cause severe bleeding and kidney problems. Prostatic artery embolization using CO2 angiography offers a safe and effective treatment option for patients with GPH and impaired kidney function.
Area of Science:
- Urology
- Interventional Radiology
Background:
- Giant prostatic hyperplasia (GPH) is a rare condition.
- Traditional treatment involves open suprapubic prostatectomy, which carries significant risks, including fatal hemorrhage.
- Patients with GPH often have diminished renal function due to obstructive nephropathy, complicating treatment choices.
Observation:
- A patient with GPH presented with intractable hematuria and compromised renal function.
- The patient was deemed unfit for conventional endovascular therapies requiring traditional contrast agents.
Findings:
- The patient underwent successful prostatic artery embolization (PAE).
- Carbon dioxide (CO2) digital subtraction arteriography was utilized as a contrast agent, avoiding iodinated contrast media.
- This approach successfully managed the hematuria and preserved renal function.
Implications:
- PAE with CO2 angiography is a viable and potentially safer alternative for treating GPH in patients with renal insufficiency.
- This technique expands endovascular treatment options for complex GPH cases.
- Further research into CO2 angiography for PAE in similar patient populations is warranted.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Venous Thrombosis III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

